Sign in
4

Changes in Ownership

Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-013819

Chief Executive Officer sold 1,074 shares at $2.77 ($2,979)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Townsend Richard Nolan Chief Executive Officer 2025-05-16 Sale −1,074 $2.77 $2,979 221,173 D
Open-market sales · 1,074 sh · avg $2.77 · $2,979
Loading xslF345X05/form4-05202025_050509.xml…